BioCentury
ARTICLE | Company News

Inhibrx, Alpha-1 Foundation deal

October 19, 2015 7:00 AM UTC

Inhibrx and Alpha-1’s Alpha-1 Project Inc. subsidiary partnered to develop a recombinant alpha-1 antitrypsin (AAT) therapeutic. Alpha-1 will make an undisclosed equity investment in Inhibrx, which is...